Substance P: The Original Tachykinin Behind Pain and Neurogenic Inflammation Research

Substance P is one of the best-known signalling peptides in neurobiology. This small 11-amino-acid neuropeptide helped researchers understand how nerves communicate with pain pathways, blood vessels, immune cells and the gut.

It is also one of the clearest examples of biological synergy. A single molecule can act like a message passed between several departments: the nervous system, immune system and digestive tract. The result depends on where Substance P is released, which receptors are present and what condition the surrounding tissue is in.

This spotlight explains the established biology behind Substance P, its main receptor, its role in pain and inflammation, and why researchers continue to study it.

Research and safety notice: Substance P research materials are not approved medicines or supplements for self-treatment. WL Australia products are intended strictly for qualified laboratory research and are not for human or animal use. Do not inject, ingest or otherwise administer research chemicals. Discuss pain, inflammation, nausea or other symptoms with a registered Australian health professional.

Substance P at a glance

The discovery: from an unknown powder to a major neuropeptide

The problem: biology was missing the messenger

In the early twentieth century, scientists knew that nerves influenced organs, but many of the chemical messengers involved had not yet been identified. Researchers could observe an effect without knowing what caused it, much like hearing a doorbell without seeing who pressed it.

In 1931, Ulf von Euler and John Gaddum reported an active substance in extracts from horse brain and intestine. The extract caused intestinal smooth muscle to contract and produced a temporary fall in blood pressure in animal experiments.

The effect was not blocked by atropine, which suggested that the substance was not simply acetylcholine. Researchers were looking at a new biological signal.

The material was eventually called Substance P. The “P” is commonly associated with the original powder preparation. Later work established that the substance was a peptide, and in 1970 researchers purified it and identified its structure as an undecapeptide, meaning a peptide containing 11 amino acids.

Short version: Substance P began as an unexplained laboratory effect and became a foundational neuropeptide discovery.

NK1R: the main receiving station

The problem: a message needs a receiver

A signalling molecule cannot do much unless a cell has the right receptor. Think of Substance P as a key and NK1R as one of its main locks.

NK1R stands for neurokinin-1 receptor. It is a G-protein-coupled receptor, or GPCR. A receptor family that changes internal cell activity after an outside signal binds to it.

Substance P can interact with several neurokinin receptors, but it has its strongest and most characteristic activity at NK1R. Once Substance P binds, NK1R can influence:

• Electrical signalling in neurons
• Blood vessel dilation
• Vascular permeability, meaning how easily fluid moves out of blood vessels
• Immune-cell communication
• Smooth muscle activity
• Pain sensitivity
• Nausea and vomiting pathways

The location of NK1R matters. It is found in the central nervous system, peripheral nerves, blood vessels, gastrointestinal tissues and immune-related cells.

The solution in research: Study the Substance P–NK1R pathway as a communication circuit rather than treating Substance P as a single-purpose “pain chemical.”

Pain transmission and nociception

The problem: an alarm system that becomes too sensitive

Nociception is the nervous system’s process for detecting potentially damaging stimuli. It is the alarm system that notices heat, pressure, chemical irritation or tissue injury.

Substance P is released by certain primary sensory neurons when these nerves are activated. In the spinal cord, it can support the transmission of pain-related signals from the body toward higher brain regions.

An everyday analogy is a relay race:

1. A sensory nerve detects a potentially harmful stimulus.
2. The signal reaches the spinal cord.
3. Substance P helps pass and amplify the message.
4. Brain networks interpret the message as pain or threat.

Substance P is especially associated with slower excitatory transmission and central sensitisation. Central sensitisation occurs when the nervous system becomes more reactive after repeated or intense stimulation. The alarm starts responding to smaller triggers, much like a smoke detector that becomes overly sensitive after repeated exposure to smoke.

This does not mean Substance P is the only cause of pain. Pain is a coordinated output involving many neurotransmitters, receptors, immune mediators and brain regions. Substance P is one important component of that network.

Research on ARA-290 and neuropathic pain biology provides a related example of how scientists investigate nerve signalling and neuroinflammation, although ARA-290 and Substance P act through different biological pathways.

Key point: Substance P participates in pain signalling; it is not a complete explanation for every pain condition.

Neurogenic inflammation and mast cells

The problem: nerves and immune cells can intensify each other

Inflammation is useful when it is controlled. It increases blood flow, recruits immune cells and helps begin repair. But if the response stays switched on, the same system can contribute to swelling, irritation and persistent sensitivity.

Neurogenic inflammation is inflammation driven or amplified by nerve activity. When sensory nerves release Substance P, nearby blood vessels may dilate and become more permeable. This can allow plasma and immune-related signals to move into surrounding tissue.

Substance P can also communicate with mast cells. Mast cells are immune cells that store and release inflammatory mediators. When activated, they can release substances such as histamine and other signalling molecules.

This creates a feedback loop:

• Nerve stimulation releases Substance P.
• Substance P activates or influences nearby immune and vascular cells.
• Inflammatory mediators increase local sensitivity.
• Increased sensitivity activates nerves again.

That is the biological equivalent of two emergency teams repeatedly escalating each other’s alerts.

The relationship is not always harmful. Substance P can contribute to host defence and early tissue repair. However, the same pathway may worsen chronic inflammation in some settings. This “friend or foe” quality is one reason Substance P research remains active and sometimes contested.

For broader context, compare this pathway with research into KPV and inflammatory signalling. These peptides are not interchangeable, but they demonstrate how researchers examine different points in the inflammation network.

The brain, spinal cord and gut

The problem: the body’s communication systems are often studied in isolation

Substance P is distributed widely across the nervous system. It is found in parts of the brain, spinal cord and peripheral sensory nerves. It is also present in the enteric nervous system. The network of neurons embedded throughout the gastrointestinal tract.

The gut is not simply a passive tube. It contains its own extensive neural network that coordinates movement, secretion and interactions with immune cells. Substance P can influence:

• Smooth muscle contraction
• Intestinal motility
• Gastrointestinal secretion
• Visceral pain signalling
• Local inflammatory responses

This helps explain why early Substance P research examined both brain and intestinal tissue. The findings were an early clue that the nervous system and gut communicate continuously.

You can think of the brain–gut axis as a two-way telephone line. Messages travel from the brain to the gut, from the gut to the brain and through local circuits within the digestive tract. Substance P is one of the signalling molecules involved in this conversation.

For a related look at gut-barrier research, see WL Australia’s article on intestinal integrity and nutrient absorption.

Wound healing and immune signalling

The problem: repair requires inflammation, but too much can delay repair

Wound healing moves through overlapping phases: inflammation, tissue formation and remodelling. Substance P has been proposed to influence several of these stages.

Research has examined possible roles in:

• Recruitment of immune cells
• Communication between nerves and immune cells
• Blood-vessel formation, also called angiogenesis
• Fibroblast activity
• Keratinocyte migration and skin repair
• Cytokine release

A cytokine is a small signalling protein used by immune and other cells to coordinate activity. Substance P may help direct these signals toward repair in some situations. In others, excessive signalling could contribute to prolonged inflammation or abnormal scarring.

The important distinction is context. A construction site needs workers and controlled activity. If every crew continues working after the building is complete, the result is not better construction. It is disorder. Biological repair follows the same principle.

NK1 antagonists: from pain research to antiemetics

The problem: blocking a receptor can reveal what the receptor does

One of the most productive ways to study Substance P has been to block NK1R and observe what changes.

Researchers initially explored NK1 receptor antagonists, compounds designed to prevent Substance P from activating NK1R, for pain and inflammatory conditions. The results for analgesia were not consistently strong enough to establish NK1 antagonists as mainstream pain medicines.

However, the pathway proved highly relevant to nausea and vomiting. NK1 antagonists such as aprepitant became important components of antiemetic treatment, particularly for chemotherapy-induced nausea and vomiting and some postoperative settings.

This is a useful lesson in drug development: a target may fail in one application but succeed in another.

NK1 antagonists have also been investigated in mood disorders, including depression. The reasoning was that Substance P and NK1R participate in stress and emotion-related brain circuits. Early findings created interest, but larger clinical studies did not produce consistent antidepressant benefits. The antidepressant application therefore remains a valuable research chapter rather than an established general treatment.

For related central nervous system research, see the Neuropeptide S product page, which also carries a clear research chemical only, not for human use notice.

What this means for Substance P research

Substance P is not a miracle molecule, a universal pain switch or a self-treatment option. It is a well-established biological signal with effects that depend on receptor location, tissue condition, timing and interactions with other systems.

Researchers continue to examine it because it sits at a busy intersection:

• Nerve-to-nerve communication
• Pain transmission
• Neurogenic inflammation
• Mast cell activity
• Immune signalling
• Gut motility
• Nausea and vomiting
• Wound repair

That breadth creates both opportunity and complexity. The more systems a peptide touches, the more important careful experimental design becomes.

\[video_placeholder_1: Animated explanation of Substance P binding to the NK1 receptor and contributing to pain signalling\]

\[video_placeholder_2: Research overview of the Substance P–NK1 pathway in neurogenic inflammation, nausea and gut function\]

Responsible research and next steps

If you are reviewing Substance P for laboratory work, focus on:

• Identity and purity: Confirm the material, analytical documentation and storage requirements.
• Experimental controls: Include appropriate receptor, vehicle and assay controls.
• Biological context: Distinguish neuronal, vascular, immune and gut effects.
• Evidence quality: Separate cell and animal findings from human clinical evidence.
• Regulatory compliance: Follow Australian requirements, institutional approvals and laboratory safety procedures.
• No self-treatment: Do not use research peptides in humans or animals.

You can review the WL Australia legal notice before considering any research purchase. If you are experiencing pain, nausea, bowel symptoms, inflammation or a wound-healing problem, seek assessment from a qualified clinician rather than attempting to manipulate Substance P or NK1R yourself.

The core principle is simple: understand the signal, identify the receptor, respect the context and keep safety ahead of experimentation.